Osteogenesis Imperfecta: Update on presentation and management
β Scribed by Moira S. Cheung; Francis H. Glorieux
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 266 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1389-9155
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
During the last 4 yr the classification of osteogenesis imperfecta (01) proposed by Sillence et a1 [1979] has become widely used and forms the basis for communication among most geneticists about this heterogeneous disorder. It was recognized then that the analysis of different types was incomplete
## Abstract Enzyme replacement therapy (ERT) with alglucosidase alpha, approved by the FDA in 2006, has expanded possibilities for individuals with Pompe disease (glycogen storage disease type II, GSDII, or acid maltase deficiency). Children with infantile Pompe disease are surviving beyond infancy